Φαρμακευτικός Κόσμος, Συμπληρώματα Διατροφής

44 117. Jureneitsch J., C. Mueller, K. Schneider, and W. Kubelka, 200 Jahre Pharmakognosie in Wien, Facultas-Universita ̈tsverlag, 1998. 118. Jurgens T. Who should be providing information to patients about herbal medicine? Canadian Journal of Clinical Pharmacology 2001;8(4):186–7. 119. Kaufman. Recent patterns of medication use in the ambulatory adult population of the United States. The Slone Survey. Journal of the American Medical Association 2002;287(3):337–44. 120. Keaney, J. F. Jr., Guo, Y., Cunningham, D., Shwaery, G. T., Xu, A. & Vita, J. A. (1996) Vascular incorporation of α-tocopherol pre- vents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. Journal of Clinical Investigation, 98, 386–94. 121. Kennedy J, Wang CC, Wu CH. Patient disclosure about herb and supplement use among adults in the US. Evid Based Complement Alternat Med. 2008;5:451–456. 122. Kim YI (2007) Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res 51, 267–292. 123. Kinsman, R. A. & Hood, J. (1971) Some behavioral effects of ascorbic acid deficiency. American Journal of Clinical Nutrition, 24, 455–64. 124. Kuriyama S, Shimazu T, Ohmori K, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan. JAMA. 2006;296:1255–1265. 125. Kuzniarz M, Mitchell P, Cumming RG & Flood VM (2001) Use of vitamin supplements and cataract: the Blue Moun- tains Eye Study. Am J Ophthalmol 132, 19–26. 126. Ladas EJ, Kroll DJ, Oberlies NH, et al. A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lympho- blastic leukemia (ALL). Cancer. 2010;116:506–513. 127. Lee, S.-S. & McCormick, D. B. (1985) Thyroid hormone regulation of flavocoenzyme biosynthesis. Archives of Biochemistry and Biophysics, 237, 197–201. 128. Leitzmann MF, Stampfer MJ, Wu K, et al. (2003) Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst 95, 1004–1007. 129. Leon AS, Spiegel HE, Thomas G, Abrams WB. Pyridoxine antagonism of levodopa in parkinsonism. JAMA. 1971;218:1924–1927. 130. Leske MC, Chylack LT Jr, He Q, Wu SY, Schoenfeld E, Friend J & Wolfe J (1998) Antioxidant vitamins and nuclear opacities: the longitudinal study of cataract. Ophthalmol- ogy 105, 831–836. 131. Lin YY, Chu SJ, Tsai SH: Association between priapism and concurrent use of risperidone and Ginkgo biloba. Mayo Clin Proc 2007; 82:1289–1290. 132. Linde K, Berner MM, Kriston L. St. John’s wort for major depression. Cochrane Database of Systematic Reviews. 2008, Issue 4. 133. Loukis A. Εφηρμοσμένη Φαρμακογνωσία. 2000. ΕΚΠΑ. Τομέας Φαρμακογνωσίας. 134. Luo JZ, Luo L. Ginseng on hyperglycemia: effects and mechanisms. eCAM 2009; 6: 423–427 135. Mahady G. B.,. Fong H. H. S, Farnsworth N. R., Botanical Dietary Supplements: quality, safety and efficacy, Swet and Zeitlinger Publishers, Lisse, Netherlands, 2001. 136. Marinac JS, Buchinger CL, Godfrey LA, Wooten JM, Sun C, Willsie SK: 
Herbal products and dietary supplements: a survey of use, attitudes, and knowledge among older adults. J Am Osteopath Assoc 2007, 107:13–20. 137. Maron DJ, Lu GP, Cai NS, et al. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: A randomized controlled trial. Arch Intern Med. 2003;163:1448–1453. 138. Mast C: Supplement sales continue strong growth trajectory in 2010.: Penton Media, Inc; 2011. Accessed 2-11-2011. [http://deliciousliving.com/ supplements/supple- ment-sales-continue-strong-growth-trajectory-2010. 139. Matthews HB, Lucier GW, Fisher KD. Medicinal Herbs in the United States: Research Needs. Environ Health Perspect. 1999 Oct;107(10):773–8. 140. McCormick, D. B., Gregory, M. E. & Snell, E. E. (1961) Pyridoxal phosphokinases. I. Assay, distribution, purification, and properties. Journal of Biological Chemistry, 236(7), 2076–84. 141. McGuffin M,Hobbs C,Upton R,Goldberg A. Botanical Safety Handbook. Boca Raton, FL:CRCPres, 197. 142. MICROMEDEX Healthcare Series [Database Online]. 2006:Vol 128 (expires 6/2006). Greenwood Village, CO: Thomson MICROMEDEX. 143. Milic N, Milosevic N, Suvajdzic L, Zarkov M, Abenavoli L. (2013). New therapeutic potentionals of milk thistle (Silybum Marianum). Nat Prod Commun. 2013 Dec;8(12):1801–10. 144. Miller L, Hume A, Harris IM, et al. White paper on herbal products. Pharmacotherapy 2000;20:877–91 145. Miller, D. R. & Hayes, K. C. (1982) Vitamin excess and toxicity. In: Nutritional Toxicology, Vol. 1. (Ed. J. N. Hathcock), pp. 81–133. Academic Press, New York. 146. Miroddi M, Mannucci C, Mancari F, Navarra M, Calapai G. Research and Development for Botanical Products in Medicinals and Food Supplements Market. Evid. Based Complement. Alternat. Med. 2013;2013:649720. 147. Montagne M. Myths & realities of alternative therapies. US Pharmacist 1999 Dec; 24:56, 63–4, 7. 148. Mosca, L., Rubenfire, M., Mandel. C., Rock, C., Tarshis, T., Tsai, A. & Pearson, T. (1997) Antioxidant nutrient supplementation re- duces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease. Journal of the American College of Cardiology, 30, 392–9. 149. MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study, Lancet, 338, 131–7. 150. Mukherjee, P. W. (2002). Quality Control of Herbal Drugs: An Approach to Evaluation of Botanicals. New Delhi, India: Business Horizons Publishers. 151. Mulholland A.C., Benford J.D. What is known about the safety of multivitamin-multimineral supplements for the generally healthy population? Theoretical basis for harm 1-4. Am J Clin Nutr 2007;85(suppl):318S–22S 152. Murphy PA, Kern SE, Stanczyk FZ, Westhoff CL: Interaction of St John’s wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Contraception 2005;71:402–408. 153. National Institute for Complementary and Alternative Medicine. Major domains of complementary and alternative medicine. Available at: http://nccam.nih.gov/nccam/ fcp/classify/. Accessed January 9, 2001. 154. National Toxicology Program. (2012). NTP toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-35-6) in F344/N rats and B6C3F1 mice (Feed Studies). Natl. Toxicol. Prog. Tech. Rep. Ser. 578, 1–224. 155. NCCAM. National Center for Complementary and Alternative Medicine. http://nccam.nih.gov 156. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007; 70: 461–477 157. Nguyen, L. B. & Gregory, J. F. III (1983) Effects of food composition on the bioavailability of vitamin B-6 in the rat. Journal of Nutrition, 113, 1550–60. 158. NUTRITION BUS. J., GLOBAL SUPPLEMENT & NUTRITION INDUSTRY REPORT 2007 (2007), http://nutritionbusinessjournal.com/nutrition-industry/market-research/ global_supplement_ nutrition_industry_report_2007/index.html (demonstrating the global nutrition industry includes dietary supplements, but also includes other prod- ucts like natural and organic foods). 159. Nygaard, O., Nordrehaug, J. E., Refsum, H., Ueland, P. M., Farstad, M. & Vollset, S. E. (1997) Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine, 337, 230–6. 160. Office of Dietary Supplements. NIH Dietary Supplement Research Centers: Botanicals. Available at http://ods.od.nih.gov/grants/diet_suppl_centers. html (accessed November 7, 2002). 161. Oldendick R, Coker AL, Wieland D. Population-based survey of complementary and alternative medicine usage, patient satisfaction, and physician involvement. South Med J 2000;93:375-81. °